The Role of Antidepressants in Bipolar Disorder

Bipolar Psychopharmacotherapy: Caring for the Patient: Second Edition

Volumn , Issue , 2011, Pages 299-316

  Yerevanian, Boghos I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

MAO Inhibitors; National Institute of Mental Health Systematic Treatment Enhancement Program for Bipolar Disorder (NIMH STEP BD); Olanzapine and fluoxetine combination (OFC); Suicidality; Tricyclic Antidepressants

Indexed keywords

EID: 84880525643     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470975114.ch15     Document Type: Chapter

References (89)

1. Agosti, V. and Stewart, J.W. (2007) Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. Int. Clin. Psychopharmacol., 22, 309-311.
2. Akiskal, H.S. (1995) Developmental pathways to bipolarity: are juvenile-onset depressions prebipolar?. J. Am. Acad. Child Adolesc. Psychiatry, 34, 754-763.
3. Akiskal, H.S., Benazzi, F., Perugi, G., and Rihmer, Z. (2005) Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J. Affect. Disord., 85, 245-258.
4. Akiskal, H.S., Hantouche, E.G., Allilaire, J.F. et al. (2003) Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J. Affect. Disord., 73, 65-74.
5. Altshuler, L., Kiriakos, L., Calcagno, J, et al. (2001) The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J. Clin. Psychiatry, 62, 612-616.
6. Altshuler, L., Post, R.M., Hellemann, G, et al. (2009) Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J. Clin. Psychiatry, 70, 450-457.
7. Altshuler, L., Post, R.M., Leverich, G.S, et al. (1995) Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry, 152, 1130-1138.
8. Altshuler, L., Suppes, T., Black, D, et al. (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 10 year follow-up. Am. J. Psychiatry, 160, 1252-1262.
9. Altshuler, L., Suppes, T., Black, D, et al. (2006) Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. Am. J. Psychiatry, 163, 313-315.
10. Amsterdam, J., Garcia-Espana, F., and Fawcett, J. (1998) Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J. Clin. Psychopharmacol., 8, 435-440.
11. Amsterdam, J.D., Wang, C.H., Shwarz, M., and Shults, J. (2009) Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. J. Affect. Disord, 112 (1-3), 219-230.
12. Angst, J., Angst, F., Gerber-Werder, R., and Gamma, A. (2005) Suicide in 406 mood-disorders patients with and without long-term medication: a 40 to 44 years' follow-up. Arch. Suicide Res., 9, 279-300.
13. APA (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry, 159, 1-50.
14. Baker, R.W., Tohen, M., Fawcett, J, et al. (2003) Acute dysphoric mania: treatment response to olanzapine versus placebo. J. Clin. Psychiatry, 23, 132-137.
15. Baĺazs, J., Benazzi, F., Rihmer, Z, et al. (2006) The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord., 91, 133-138.
16. Baldessarini, R.J., Tondo, L., Davis, P, et al. (2006) Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord., 8, 625-639.
17. Bauer, M., Rasgon, N., Grof, P, et al. (2005) Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting. Psychiatry Res., 133, 73-80.
18. Bauer, M., Wisniewski, S.R., Marangell, L.B, et al. (2006) Are antidepressants associated with new-onset suicidality in bipolar disorder? J. Clin. Psychiatry, 67, 48-55.
19. Benazzi, F., Berk, M., Frye, M.A, et al. (2009) Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. J. Clin. Psychiatry, 70, 1424-1431.
20. Bond, D.J., Noronha, M.M., Kauer-Sant'Anna, M, et al. (2008) Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis. J. Clin. Psychiatry, 69, 1589-1601.
21. Bowden, C.L., Calbrese, J.R., McElroy, S.L, et al., Divalproex Maintenance Study Group (2000) A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen. Psychiatry, 57, 481-489.
22. Brent, D. (2007) Antidepressants and suicidal behavior: cause or cure? Am. J. Psychiatry, 164, 989-991.
23. Bridge, J., Iyengar, S., Salary, C, et al. (2007) Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. A meta-analysis of randomized controlled trials. J. Am. Med. Assoc., 297, 1683-1696.
24. Brown, E., Dunner, D.L., McElroy, S.L, et al. (2009) Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. Int. J. Neuropsychopharmacol., 12, 773-782.
25. Brown, E.B., McElroy, S.L., Keck, P.E. Jr, et al. (2006) A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J. Clin. Psychiatry, 67, 1025-1033.
26. Fergusson, D., Doucette, S., Glass, K.C., et al., (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. BMJ, 330, 396.
27. Fonseca, M., Soares, J.C., Hatch, J.P, et al. (2006) An open trial of adjunctive escitalopram in bipolar depression. J. Clin. Psychiatry, 67, 81-86.
28. Fountoulakis, K.N. and Vieta, E. (2008) Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int. J. Neuropsychopharmacol., 11, 999-1029.
29. Frye, M.A., Helleman, G., McElroy, S.L., et al., (2009) Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am. J. Psychiatry, 166 (2), 164-172.
30. Gao, K., Kemp, D.E., Ganocy, S.J, et al. (2008) Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disord., 10, 907-915.
31. Ghaemi, S.N., Hsu, D.J., Soldani, F., and Goodwin, F.K. (2003) Antidepressants in bipolar depression: the case for caution. Bipolar Disord., 5, 421-433.
32. Ghaemi, S.N., Lenox, M.S., and Baldessarini, R.J. (2001) Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. J. Clin. Psychiatry, 62, 565-569.
33. Ghaemi, S.N., Rosenquist, Kj., Ko, J.Y, et al. (2004) Antidepressant treatment in bipolar versus unipolar depression. Am. J. Psychiatry, 161, 163-165.
34. Ghaemi, S.N., Wingo, W.P., Filkowski, M.A., and Baqldessarini, R.J. (2008) Long-term antidepressant treatment in bipolar disorder: mata-analyses of benefits and risks. Acta Psychiatr. Scand., 118, 347-356.
35. Gijsman, H.J., Geddes, J.R., Rendell, J.M, et al. (2004) Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am. J. Psychiatry, 161, 1537-1547.
36. Goldberg, J.F., Allen, M.H., Miklowitz, D.A, et al., (2005) Suicidal ideation and pharmacotherapy among STEP-BD patients. Psych. Serv., 56 (12), 1534-1540.
37. Goldberg, J.F., Garno, J.L., Portera, L, et al. (1999) Correlates of suicidal ideation in dysphoric mania. J. Affect. Disord., 56, 75-81.
38. Goldberg, J.F., Perlis, R.H., Ghaemi, S.N, et al. (2007) Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am. J. Psychiatry, 164, 1348-1355.
39. Goodnick, P.J. (2007) Bipolar depression: a review of randomized clinical trials. Expert. Opin. Pharmacother., 8, 13-21.
40. Goodwin, G.M. (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol., 17, 149-173; discussion 147.
41. Goodwin, F.K. and Jamison, K.R. (2007) Manic-Depressive Illness; Bipolar Disorders and Recurrent Depression, 2nd edn, Oxford University Press.
42. Grunze, H., Kasper, S., Goodwin, G, et al. (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J. Biol. Psychiatry, 3, 115-124.
43. Haykal, R.F. and Akiskal, H.S. (1990) Bupropion as a promising approach to rapid-cycling bipolar II patients. J. Clin. Psychiatry, 51, 450-455.
44. Himmelhoch, J.M., Thase, M.E., Mallinger, A.G., and Houck, P. (1991) Tranylcypromine versus imipramine in anergic bipolar depression. Am. J. Psychiatry, 148, 910-916.
45. Judd, L.L., Akiskal, H.S., Schettler, P.J, et al., (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry, 59 (6), 530-537.
46. Judd, L.L., Schettler, P.J., Akiskal, H.S, et al. (2003) Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int. J. Neuropsychopharmacol., 6, 127-137.
47. Kane, J.M., Quitkin, F.M., and Rifkin, A. (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch. Gen. Psychiatry, 39, 1065-1069.
48. Kessing, L.V., Sønderg°ard, L., Kvist, K., and Anderson, P.K. (2005) Suicide risk in patients treated with lithium. Arch Gen. Psychiatry, 62, 860-866.
49. Koszewska, I. and Rybakowski, J.K. (2009) Antidepressant-induced mood conversions in bipolar disorder: a retrospective study of tricyclic versus non-tricyclic antidepressant drugs. Neuropsychobiology, 59, 12-16.
50. Kupfer, D.J., Chengappa, K.N., Gelenberg, A.J, et al. (2001) Citalopram as adjunctive therapy in bipolar depression. J. Clin. Psychiatry, 62, 985-990.
51. Landry, P. (1997) Withdrawal hypomania associated with paroxetine. J. Clin. Psychopharmacol., 17, 60-61.
52. Leverich, G.S., Altshuler, L.L., Frye, M.A, et al. (2006) Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am. J. Psychiatry, 163, 232-239.
53. Mallinger, A.G., Frank, E., Thase, M.E, et al. (2009) Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior? Psychopharmacol. Bull., 42, 64-74.
54. Marangell, L.B., Dennehy, F.B., Wisniewski, S.R, et al. (2008) Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J. Clin. Psychiatry, 69, 916-922.
55. McElroy, S.L., Kotwal, R., Kaneria, R., and Keck, P.E. (2006) Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord., 8, 596-617.
56. Moller, H.J., Bottlender, R., Grunze, H, et al. (2001) Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? J. Affect. Disord., 67, 141-146.
57. Moller, H.J. and Grunze, H. (2000) Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur. Arch Psychiatry Clin. Neurosci., 250, 57-68.
58. Mundo, E., Walker, M., Cate, T, et al. (2001) The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Arch Gen. Psychiatry, 58, 539-544.
59. Nemeroff, C.B., Evans, D.L., Gyulai, L, et al. (2001) Double-blind, placebo controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am. J. Psychiatry, 158, 906-912.
60. Nolen, W.A., Kupka, R.W., Hellemann, G, et al. (2007) Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr. Scand., 11, 360-365.
61. Parker, G., Tully, L., Olley, A., and Hadzi-Pavlovic, D. (2006) SSRIs as mood stabilizers for bipolar ii disorder? A proof of concept study. J. Affect. Disord., 92, 205-214.
62. Post, R.M., Altshuler, L.L., Frye, M.A, et al. (2001) Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord., 3, 259-265.
63. Post, R.M., Altshuler, L.L., Leverich, G.S, et al. (2006) Mood switch in bipolar depression: comparison of adjunctive velafaxine, bupropion, and sertraline. Br. J. Psychiatry, 189, 124-131.
64. Post, R.M., Leverich, G.S., Nolen, W.A, et al. (2003) A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord., 5, 396-406.
65. Prien, R.F., Klett, C.J., and Caffey, E.M. (1979) Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen. Psychiatry, 29, 420-425.
66. Quitkin, F.M., Kane, J., Rifkin, A, et al. (1981) Prophylactic lithium carbonate with and without imipramine for bipolar I patients. Arch Gen. Psychiatry, 38, 902-907.
67. Rihmer, Z. and Akiskal, H. (2006) Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord., 94, 94-913.
68. Sachs, G.S., Nierenberg, A.A., Calabrese, J.R, et al. (2007) Effectiveness of adjunctive antidepressant treatment for bipolar depression. N. Engl. J. Med., 356, 1711-1722.
69. Sachs, G.S., Printz, D.J., Kahn, D.A, et al. (2000) The expert consensus guidelines series: medication treatment of bipolar disorder 2000. Postgrad. Med., April, Spec No. 1-104.
70. Sachs, G.S., Thase, M.E., Otto, M.W, et al. (1994) A double-blind trial of buproprion versus desipramine for bipolar depression. J. Clin. Psychiatry, 55, 391-393.
71. Schaffer, A., Zuker, P., and Levitt, A. (2006) Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J. Affect. Disord., 96, 95-99.
72. Shi, L., Thiebaud, P., and McCombs, J.S. (2004) The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J. Affect. Disord., 82, 373-383.
73. Sidor, M.M., and Macqueen, G.M. (2010) Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. J. Clin. Psychiatry. (Epub)
74. Silverstone, T. (2001) Moclobemide vs. imipramine in bipolar depression: a multicentre doubleblind clinical trial. Acta Psychiatr. Scand., 104, 104-109.
75. Simon, N.M., Otto, M.W., Weiss, R.D, et al. (2004) Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J. Clin. Psychopharmacol., 24, 512-520.
76. Simpson, S.G. and DePaulo, J.R. (1991) Fluoxetine treatment of bipolar II depression. J. Clin. Psychopharmacol., 11, 52-54.
77. Stoll, A.L., Mayer, P.V., Kolbrener, M, et al., (1994) Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am. J. Psychiatry, 151 (11), 1642-1645.
78. Tamayo, J.M., Sutton, V.K., Mattei, M.A, et al. (2009) Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. J. Clin. Psychiatry, 29 (4), 358-361.
79. Thase, M.E., Mallinger, A.G., McKnight, D., and Himmelhoch, J.M. (1992) Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. Am. J. Psychiatry, 149 (2), 195-198.
80. Tohen, M., Vieta, E., Calabrese, J, et al. (2003) Efficacy of olanzapine and olanzapinefluoxetine combination in the treatment of bipolar I depression. Arch Gen. Psychiatry, 60, 1079-1088.
81. Valuck, R.J., Orton, H.D., and Libby, A.M. (2009) Antidepressant discontinuation and risk of suicide attempt: a retrospective, nested case-control study. J. Clin. Psychiatry, 70, 1069-1077.
82. Vasquez, G., Tondo, L., and Baldessarini, R.J. (2010) Comparison of antidepressant responses in patients with bipolar vs unipolar depression: a meta-analytic review. Pharmacopsychiatry (Epub).
83. Vieta, E., Berk, M., Wang, W, et al. (2009) Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J. Affect. Disord., 119, 22-27.
84. Vieta, E., Martinez-Aran, A., Goikolea, J.M, et al. (2002) A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood-stabilizers. J. Clin. Psychiatry, 63, 508-512.
85. Wehr, T.A. and Goodwin, F.K. (1979) Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen. Psychiatry, 36, 555-559.
86. Yatham, L.N., Kennedy, S.H., O'Donovan, C, et al. (2006) Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord., 8, 721-739.
87. Yerevanian, B.I., Koek, R.J., Feusner, J.D, et al. (2004) Antidepressants and suicidal behavior in unipolar depression. Acta Psychiatr. Scand., 110, 452-458.
88. Yerevanian, B.I., Koek, R.J., and Mintz, J. (2007) Bipolar pharmacotherapy and suicidal behavior: Part I: Lithium, divalproex, and carbamazepine. J. Affect. Disord., 103, 5-11.
89. Young, L.T., Joffe, R.T., Robb, J.C, et al. (2000) Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am. J. Psychiatry, 157, 124-126.